DevicePMAs@therightstef:P990078_S000 JSONTXT

{"project":"PMA_MER","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25425"},{"id":"T2","span":{"begin":55,"end":61},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62103"},{"id":"T3","span":{"begin":79,"end":88},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C53288"},{"id":"T4","span":{"begin":89,"end":98},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157203"},{"id":"T5","span":{"begin":185,"end":195},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48793"},{"id":"T6","span":{"begin":220,"end":225},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63534"},{"id":"T7","span":{"begin":232,"end":240},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63806"},{"id":"T8","span":{"begin":300,"end":303},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25150"},{"id":"T9","span":{"begin":318,"end":328},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25356"},{"id":"T10","span":{"begin":329,"end":338},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54072"},{"id":"T11","span":{"begin":361,"end":366},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25629"},{"id":"T12","span":{"begin":398,"end":404},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25446"}],"text":"Approval for the sunrise hyperion(tm) ltk system. The device is indicated for temporary reduction of hyperopia in patients with +0.75 to +2.5 diopters of manifest refraction sphericla equivalent (mrse) at the spectacle plane (with cylinder less than or equal to +-0.75 diopters) who are 40 years of age or older with documented stability of refraction for the prior 6 months, as demonstrated by a change of less than or equal to 0.50d in spherical, and cylindrical components of the manifest refracs"}

{"project":"PMA_age_indications","denotations":[{"id":"T5","span":{"begin":288,"end":290},"obj":"age_start"},{"id":"T1","span":{"begin":288,"end":312},"obj":"age_range"},{"id":"T4","span":{"begin":291,"end":296},"obj":"age_start_unit"},{"id":"T3","span":{"begin":307,"end":312},"obj":"age_end"}],"text":"Approval for the sunrise hyperion(tm) ltk system. The device is indicated for temporary reduction of hyperopia in patients with +0.75 to +2.5 diopters of manifest refraction sphericla equivalent (mrse) at the spectacle plane (with cylinder less than or equal to +-0.75 diopters) who are 40 years of age or older with documented stability of refraction for the prior 6 months, as demonstrated by a change of less than or equal to 0.50d in spherical, and cylindrical components of the manifest refracs"}

{"project":"consensus_PMA_Age_Indications","denotations":[{"id":"T1","span":{"begin":288,"end":312},"obj":"age_range"},{"id":"T5","span":{"begin":288,"end":290},"obj":"age_start"},{"id":"T4","span":{"begin":291,"end":296},"obj":"age_start_unit"},{"id":"T3","span":{"begin":307,"end":312},"obj":"age_end"}],"text":"Approval for the sunrise hyperion(tm) ltk system. The device is indicated for temporary reduction of hyperopia in patients with +0.75 to +2.5 diopters of manifest refraction sphericla equivalent (mrse) at the spectacle plane (with cylinder less than or equal to +-0.75 diopters) who are 40 years of age or older with documented stability of refraction for the prior 6 months, as demonstrated by a change of less than or equal to 0.50d in spherical, and cylindrical components of the manifest refracs"}

{"project":"Age_blah","denotations":[{"id":"T1","span":{"begin":288,"end":290},"obj":"age_start"},{"id":"T2","span":{"begin":291,"end":296},"obj":"age_start_unit"},{"id":"T3","span":{"begin":307,"end":312},"obj":"age_end"},{"id":"T4","span":{"begin":288,"end":312},"obj":"age_range"}],"text":"Approval for the sunrise hyperion(tm) ltk system. The device is indicated for temporary reduction of hyperopia in patients with +0.75 to +2.5 diopters of manifest refraction sphericla equivalent (mrse) at the spectacle plane (with cylinder less than or equal to +-0.75 diopters) who are 40 years of age or older with documented stability of refraction for the prior 6 months, as demonstrated by a change of less than or equal to 0.50d in spherical, and cylindrical components of the manifest refracs"}

{"project":"Age_blah","denotations":[{"id":"T1","span":{"begin":288,"end":290},"obj":"age_start"},{"id":"T2","span":{"begin":291,"end":296},"obj":"age_start_unit"},{"id":"T3","span":{"begin":307,"end":312},"obj":"age_end"},{"id":"T4","span":{"begin":288,"end":312},"obj":"age_range"}],"text":"Approval for the sunrise hyperion(tm) ltk system. The device is indicated for temporary reduction of hyperopia in patients with +0.75 to +2.5 diopters of manifest refraction sphericla equivalent (mrse) at the spectacle plane (with cylinder less than or equal to +-0.75 diopters) who are 40 years of age or older with documented stability of refraction for the prior 6 months, as demonstrated by a change of less than or equal to 0.50d in spherical, and cylindrical components of the manifest refracs"}

{"project":"updated_tagging_age_PMA_annotations","denotations":[{"id":"T1","span":{"begin":288,"end":312},"obj":"age_range"},{"id":"T3","span":{"begin":307,"end":312},"obj":"age_end"},{"id":"T4","span":{"begin":291,"end":296},"obj":"age_start_unit"},{"id":"T5","span":{"begin":288,"end":290},"obj":"age_start"}],"text":"Approval for the sunrise hyperion(tm) ltk system. The device is indicated for temporary reduction of hyperopia in patients with +0.75 to +2.5 diopters of manifest refraction sphericla equivalent (mrse) at the spectacle plane (with cylinder less than or equal to +-0.75 diopters) who are 40 years of age or older with documented stability of refraction for the prior 6 months, as demonstrated by a change of less than or equal to 0.50d in spherical, and cylindrical components of the manifest refracs"}